Influencing factors and clinical significance of liver function damage in patients diagnosed with COVID-19
Q4 Medicine
Da-wei Sun, Dong Zhang, Runhui Tian, Yang Li, Yu-Shi Wang, Jie Cao, Ying Tang, N. Zhang, Tao Zan, Lan Gao, Yanzhu Huang, Yang Zheng, Guoyue Lyu
{"title":"Influencing factors and clinical significance of liver function damage in patients diagnosed with COVID-19","authors":"Da-wei Sun, Dong Zhang, Runhui Tian, Yang Li, Yu-Shi Wang, Jie Cao, Ying Tang, N. Zhang, Tao Zan, Lan Gao, Yanzhu Huang, Yang Zheng, Guoyue Lyu","doi":"10.3760/CMA.J.CN115610-20200229-00133","DOIUrl":null,"url":null,"abstract":"Objective: To invetigate the influencing factors and clinical significance of liver function damage (LFD) in patients diagnosed with Corona Virus Disease 2019 (COVID-19) Methods: The retrospective case-control study was conducted The clinicopathological data of 51 patients with COVID-19 who were admitted to the Sino-French New City Branch of Tongji Hospital Affiliated to Huazhong University of Science and Technology by the 5th group assisting team from the First Hospital of Jilin University from February 9th to 27th in 2020 were collected There were 27 males and 24 females, aged from 36 to 86 years, with an average age of 68 years The treatment modality was according to the diagnostic and therapeutic guideline for COVID-19 (Trial 6th edition) issued by National Health Commission Observation indicators: (1) clinical data of patients;(2) analysis of liver function index and treatment of LFD;(3) analysis of influencing factors for LFD Measurement data with normal distribution were represented as Mean±SD, and measurement data with skewed distribution were described as M (range) Count data were described as absolute numbers or percentages, and comparison between groups was analyzed using the chi-square test The Logistic regression method was used for univariate analysis Results: (1) Clinical data of patients: of the 51 patients, 21 were classified as ordinary type of COVID-19, 19 as severe type and 11 as critical type In terms of medical history, 31 patients suffered from more than or equal to one kind of chronic disease, 20 had no history of chronic disease Thirteen patients had the drinking history and 38 had no drinking history Seven patients were hepatitis positive and 44 were hepatitis negative Five patients had septic shock at admission, 5 had systemic inflammatory response syndrome (SIRS), and 41 had neither shock nor SIRS The body mass index (BMI), time from onset to admission, temperature, heart rate, respiratory rate of the 51 patients were (24±3)kg/m2, (13±5)days, 36 5 ℃ (range, 36 0-38 1 ℃), 82 times/minutes (range, 50-133 times/minutes), 20 times/minutes (range, 12-40 times/minutes) The white blood cell count, level of creatinine, and level of b-type natriuretic peptide within 24 hours after admission were 6 3×109/L [range, (2 2-21 7)×109/L], 75 μmol/L (range, 44-342 μmol/L), 214 ng/L (range, 5-32 407 ng/L) (2) Analysis of liver function index and treatment of LFD: the level of alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutamyl transpeptidase (GGT), alkaline phosphatase (ALP), direct bilirubin (DBil), indirect bilirubin (IBil), activated partial thromboplastin time (APTT) and prothrombin time (PT) were 31 U/L (range, 7-421 U/L), 29 U/L (range, 15-783 U/L), 36 U/L (range, 13-936 U/L), 76 U/L (range, 41-321 U/L), 4 9 μmol/L (range, 2 6-14 3 μmol/L), 5 8 μmol/L (range, 2 6-23 9 μmol/L), 37 2 s (range, 30 9-77 1 s), 13 9 s (range, 12 5-26 7 s), respectively The percentages of cases with abnormal ALT, AST, GGT, ALP, DBil, IBil, APTT and PT were 47 1%(24/51), 47 1%(24/51), 35 3%(18/51), 13 7%(7/51), 7 8%(4/51), 2 0%(1/51), 21 6%(11/51), and 19 6%(10/51), respectively Of the 51 patients, LFD was detected in 10 patients classified as ordinary type, in 9 patients as severe type, and in 10 as critical type, respectively In the 51 patients, 1 of 22 patients with normal liver function developed respiratory failure and received mechanical ventilation within 24 hours after admission, while 9 of 29 patients with abnormal liver function developed respiratory failure and received mechanical ventilation, showing a significant difference between the two groups (χ2=5 57, P<0 05) (3) Analysis of influencing factors for LFD Results of univariate analysis showed that clinical classification of COVID-19 as critical type was a related factor for LFD of patients (odds ratio=10 000, 95% confidence interval: 1 050-95 231, P<0 05) Conclusions: COVID-19 patients with LFD are more susceptible to develop respiratory failure The clinical classification of COVID-19 as cr tical type is a related factor for LFD of patients Copyright © 2020 by the Chinese Medical Association","PeriodicalId":36400,"journal":{"name":"中华消化外科杂志","volume":"19 1","pages":"360-365"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华消化外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN115610-20200229-00133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Objective: To invetigate the influencing factors and clinical significance of liver function damage (LFD) in patients diagnosed with Corona Virus Disease 2019 (COVID-19) Methods: The retrospective case-control study was conducted The clinicopathological data of 51 patients with COVID-19 who were admitted to the Sino-French New City Branch of Tongji Hospital Affiliated to Huazhong University of Science and Technology by the 5th group assisting team from the First Hospital of Jilin University from February 9th to 27th in 2020 were collected There were 27 males and 24 females, aged from 36 to 86 years, with an average age of 68 years The treatment modality was according to the diagnostic and therapeutic guideline for COVID-19 (Trial 6th edition) issued by National Health Commission Observation indicators: (1) clinical data of patients;(2) analysis of liver function index and treatment of LFD;(3) analysis of influencing factors for LFD Measurement data with normal distribution were represented as Mean±SD, and measurement data with skewed distribution were described as M (range) Count data were described as absolute numbers or percentages, and comparison between groups was analyzed using the chi-square test The Logistic regression method was used for univariate analysis Results: (1) Clinical data of patients: of the 51 patients, 21 were classified as ordinary type of COVID-19, 19 as severe type and 11 as critical type In terms of medical history, 31 patients suffered from more than or equal to one kind of chronic disease, 20 had no history of chronic disease Thirteen patients had the drinking history and 38 had no drinking history Seven patients were hepatitis positive and 44 were hepatitis negative Five patients had septic shock at admission, 5 had systemic inflammatory response syndrome (SIRS), and 41 had neither shock nor SIRS The body mass index (BMI), time from onset to admission, temperature, heart rate, respiratory rate of the 51 patients were (24±3)kg/m2, (13±5)days, 36 5 ℃ (range, 36 0-38 1 ℃), 82 times/minutes (range, 50-133 times/minutes), 20 times/minutes (range, 12-40 times/minutes) The white blood cell count, level of creatinine, and level of b-type natriuretic peptide within 24 hours after admission were 6 3×109/L [range, (2 2-21 7)×109/L], 75 μmol/L (range, 44-342 μmol/L), 214 ng/L (range, 5-32 407 ng/L) (2) Analysis of liver function index and treatment of LFD: the level of alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutamyl transpeptidase (GGT), alkaline phosphatase (ALP), direct bilirubin (DBil), indirect bilirubin (IBil), activated partial thromboplastin time (APTT) and prothrombin time (PT) were 31 U/L (range, 7-421 U/L), 29 U/L (range, 15-783 U/L), 36 U/L (range, 13-936 U/L), 76 U/L (range, 41-321 U/L), 4 9 μmol/L (range, 2 6-14 3 μmol/L), 5 8 μmol/L (range, 2 6-23 9 μmol/L), 37 2 s (range, 30 9-77 1 s), 13 9 s (range, 12 5-26 7 s), respectively The percentages of cases with abnormal ALT, AST, GGT, ALP, DBil, IBil, APTT and PT were 47 1%(24/51), 47 1%(24/51), 35 3%(18/51), 13 7%(7/51), 7 8%(4/51), 2 0%(1/51), 21 6%(11/51), and 19 6%(10/51), respectively Of the 51 patients, LFD was detected in 10 patients classified as ordinary type, in 9 patients as severe type, and in 10 as critical type, respectively In the 51 patients, 1 of 22 patients with normal liver function developed respiratory failure and received mechanical ventilation within 24 hours after admission, while 9 of 29 patients with abnormal liver function developed respiratory failure and received mechanical ventilation, showing a significant difference between the two groups (χ2=5 57, P<0 05) (3) Analysis of influencing factors for LFD Results of univariate analysis showed that clinical classification of COVID-19 as critical type was a related factor for LFD of patients (odds ratio=10 000, 95% confidence interval: 1 050-95 231, P<0 05) Conclusions: COVID-19 patients with LFD are more susceptible to develop respiratory failure The clinical classification of COVID-19 as cr tical type is a related factor for LFD of patients Copyright © 2020 by the Chinese Medical Association
新冠肺炎患者肝功能损害的影响因素及临床意义
目的:探讨2019冠状病毒病(COVID-19)患者肝功能损害(LFD)的影响因素及临床意义收集吉林大学第一医院2020年2月9日至27日第五批援吉林科技队的科技资料,平均年龄68岁,治疗方式按照国家卫生健康委员会发布的《新冠肺炎诊疗指南(试行第6版)》观察指标:(1)患者临床资料;(2) 肝功能指标分析及LFD的治疗;(3) LFD影响因素分析正态分布的测量数据用平均值±SD表示,偏态分布的数据用M(范围)表示。计数数据用绝对数或百分比表示,结果:(1)患者临床资料:51例患者中,21例为新冠肺炎普通型,19例为重症,11例为危重型,20名患者无慢性病史13名患者有饮酒史,38名患者无饮酒史7名患者肝炎阳性,44名患者肝炎阴性5名患者入院时出现感染性休克,5名患者出现全身炎症反应综合征(SIRS),41名患者既没有休克也没有SIRS,51例患者的呼吸频率分别为(24±3)kg/m2、(13±5)d、36.5℃(范围,36 0-38 1℃)、82次/分钟(范围,50-133次/分钟)、20次/分钟,214 ng/L(范围:5-32 407 ng/L)(2)肝功能指标分析及LFD治疗:丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、谷氨酰转肽酶(GGT)、碱性磷酸酶(ALP)、直接胆红素(DBil)、间接胆红素(IBil)、活化部分凝血活酶时间(APTT)和凝血酶原时间(PT)分别为31 U/L(范围:7-421 U/L),29 U/L(范围,15-783 U/L)、36 U/L(范,13-936 U/L 24/51)、35.3%(18/51)、13.7%(7/51)、7.8%(4/51)、2.0%(1/51),51例患者中,10例为普通型、9例为重型、10例为危重型,LFD检出率分别为21.6%(11/51)和19.6%(10/51),29例肝功能异常患者中有9例出现呼吸衰竭并接受机械通气,LFD的影响因素分析单因素分析结果显示,新冠肺炎临床分型为危重型是LFD患者的相关因素(比值比为10 000,95%置信区间:1 050-95 231,P<0 5)呼吸衰竭新冠肺炎临床分型是患者LFD的相关因素版权所有©2020中华医学会
本文章由计算机程序翻译,如有差异,请以英文原文为准。